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Classical swine fever (CSF) is a highly contagious viral dis-
ease of domestic and wild pigs. The etiological agent is the 
Classical swine fever virus (CSFV), an enveloped virus 
belonging to the genus Pestivirus in the family Flaviviridae. 
Other animal pathogens within this genus include Bovine 
viral diarrhea virus 1 and 2 (BVDV) and Border disease 
virus (BDV), both of which can infect pigs.4 Although 
BVDV and BDV do not cause clinical disease in swine, anti-
bodies produced in pigs infected with these agents are 
cross-reactive with CSFV antigen, reducing the specificity 
of serological-based assays.9
Some of the current diagnostic methods for CSF include 
the detection of viral antigens in tonsils using fluorescent con-
jugated antibody, antigen capture enzyme-linked immunosor-
bent assays (ELISAs),2 or detection of genomic RNA by 
reverse transcription polymerase chain reaction (RT-PCR).5,6,10 
The disease may present in a peracute, acute, subacute, 
chronic, or persistent form. Subacute and chronic forms of 
CSF are often associated with previously vaccinated herds or 
low virulence viruses and may remain clinically undetected.9 
In this regard, infection with low virulent viruses often do not 
present with clinical signs consistent with CSF. As CSF is 
classified as a notifiable disease to the World Organization for 
Animal Health (OIE) and the economic consequences of an 
outbreak are significant, rapid and accurate diagnosis or rule-
out of CSF is essential. This is particularly the case, as sero-
logical and antigen tests incur a potentially high false-positive 
rate due to cross-reactivity occurring with BVDV and BDV.2,4
The objective of the current study was to develop a reli-
able, sensitive, and specific real-time reverse transcription 
polymerase chain reaction (real-time RT-PCR) test for CSF 
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Abstract. Classical swine fever (CSF) is an economically devastating disease of pigs. Instrumental to the control of CSF is a 
well-characterized assay that can deliver a rapid, accurate diagnosis prior to the onset of clinical signs. A real-time fluorogenic-
probe hydrolysis (TaqMan) reverse transcription polymerase chain reaction (RT-PCR) for CSF was developed by the United 
States Department of Agriculture (USDA) at the Plum Island Animal Disease Center (CSF PIADC assay) and evaluated for 
analytical and diagnostic sensitivity and specificity. A well-characterized panel including Classical swine fever virus (CSFV), 
Bovine viral diarrhea virus (BVDV), and Border disease virus (BDV) isolates was utilized in initial feasibility and optimization 
studies. The assay was initially designed and validated for use on the ABI 7900HT using the Qiagen QuantiTect® Probe 
RT-PCR chemistry. However, demonstrating equivalency with multiple one-step RT-PCR chemistries and PCR platforms 
increased the versatility of the assay. Limit of detection experiments indicated that the Qiagen QuantiTect® Multiplex (NoROX) 
and the Invitrogen SuperScript® III RT-PCR kits were consistently the most sensitive one-step chemistries for use with the CSF 
PIADC primer/probe set. Analytical sensitivity of the CSF PIADC assay ranged from <1–2.95 log
10
 TCID
50
/ml on both the 
ABI 7900HT and ABI 7500 platforms. The CSF PIADC assay had 100% diagnostic sensitivity and specificity when tested on 
a panel of 152 clinical samples from the Dominican Republic and Colombia. The ability to perform this newly developed assay 
in 96-well formats provides an increased level of versatility for use in CSF surveillance programs.
Key words: Blood; classical swine fever; hog cholera; virus; Classical swine fever virus; swine; pigs; RNA; real-time 
reverse transcription polymerase chain reaction.
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and validate it for fitness for use with nasal swabs from 
pigs. The new assay, named Classical Swine Fever Plum 
Island Animal Disease Center (PIADC CSF) real-time 
RT-PCR, was compared with the previously developed 
Risatti CSF real-time RT-PCR8 assay deployed for use in 
the U.S. CSF Surveillance Program. Experimental observa-
tions including assay equivalency, repeatability, and agree-
ment were evaluated and determined using statistical 
analyses to compare the PIADC CSF assay to the previ-
ously developed Risatti CSF assay.8 Beyond this study is 
the additional validation of the PIADC CSF assay on other 
clinical sample types, such as whole blood from swine.3
Viral RNA was purified from cell culture propagated 
virus and clinical swab samples using a commercial kit.a A 
total of 160 sequences spanning all major genotypic groups 
and subgroups of CSFV, including 105 CSFV, 28 BVDV, 
and 27 BDV strains, were aligned to genotype 1.1 reference 
CSFV Alfort 187 using BioEdit software.b This alignment 
was used to design a TaqMan probe,c forward and reverse 
primersd for the PIADC CSF assay (Table 1). All primers 
were synthesized and purified by column purification.d Probe 
sequences were synthesized and labeled with 6-carboxyfluo-
rescein (FAM)d at the 5′ end and with minor groove-binding 
nonfluorescent quencher dye (MGBNFQ)e at the 3′ end. 
Three, one-step RT-PCR kits were tested to optimize the new 
assay: the QuantiTect® Probe RT-PCR Kit,f QuantiTect® 
Multiplex-NR RT-PCR NoROX Kit,g and SuperScript® III 
RT-PCR Kit.h For the PIADC CSF assay, the final reaction 
mixture consisted of 22.5 µl of master mix including opti-
mized concentrations of 0.2 µM forward primer, 0.4 µM 
reverse primer, and 0.2 µM probe (Table 1), and 2.5 µl of 
viral RNA. Additionally, ROXi (2.5 µM) was added to a final 
concentration of 50 nM to the Multiplex-NRg and SuperScript 
IIIh master mixes for use with the PIADC CSF assay on the 
ABI 7500 Fastj platform. Alternately, ROX (25 µM) was 
added to a final concentration of 500 nM to the Multiplex-NR 
and SuperScript III master mixes for use with the PIADC 
CSF assay on the ABI 7900HTk platform.
Cycling conditions on the ABI 7900HT and ABI 7500 
were as follows: reverse transcription at 50°C for 30 min, 
enzyme activation at 95°C for 15 min, followed by 45 cycles 
at 94°C for 15 sec and 56°C for 60 sec. Fluorescence data 
for all real-time RT-PCR assays were acquired during the 
annealing and extension phase in the reaction using the FAM 
detection channel on each instrument. The results were des-
ignated positive for threshold cycle (Ct) values <40, and 
negative for a Ct values ≥40 or negative for samples with 
which threshold had not been attained before cycling com-
pleted at 45 cycles. Positive and negative amplification and 
extraction controls were included in each evaluation. The 
CSF PIADC assay was performed on the ABI 7900HT and 
ABI 7500 (in standard mode), and the Risatti CSF assay was 
performed on the SmartCycler IIl and ABI 7900HT for 
direct comparison of the assays without differences due to 
the platform.
Analytical sensitivity and specificity of the CSF PIADC 
assay were determined using a panel of 157 CSFV, 6 BVDV, 
and 3 BDV isolates, and pestivirus-negative samples. The ana-
lytical panel of virus isolates was evaluated using the opti-
mized assay conditions (above) for the CSF PIADC assay 
on the ABI 7900HT and ABI 7500 platforms and the Risatti 
CSF assay on the SmartCycler II platform (raw data not 
shown). Raw data from an additional smaller representa-
tive panel of 21 CSFV, 6 BDV, and 5 BVDV isolates is pre-
sented (Table 2).
For sensitivity and limit of detection (LOD) studies, 
infectious titers of 9 different CSF isolates were determined 
by calculating end-point titrations using median tissue cul-
ture infectious dose (TCID
50
; Table 3). Analytical perfor-
mances and sensitivities of the CSF PIADC assay were 
determined by analyzing 10-fold dilutions of purified CSFV 
RNA from titered isolates of CSFV using master mixes pre-
pared from the Probe, Multiplex-NR, and SuperScript III 
chemistries and amplification on the ABI 7900HT or ABI 
7500 platforms (Table 3). Diagnostic sensitivity and speci-
ficity were determined by testing 58 known positive nasal 
swab samples from the Dominican Republic7 and 93 known 
negative nasal swab samples from Colombia7 using the opti-
mized CSF PIADC and Risatti CSF assays.
Using a large panel of 157 CSFV, 6 BVDV, and 3 BDV 
isolates, analytical sensitivity was found to be greater than 
0.99 (95% confidence interval [CI]: 0.96, 1.00) for both the 
CSF PIADC and the Risatti CSF assays. Analytical speci-
ficities were 0.92 (95% CI: 0.58, 0.99) and 0.68 (95% CI: 
0.40, 0.87) for the CSF PIADC and Risatti CSF assays, 
respectively. Both assays resulted in negative reactions for 
all BVDV isolates tested; however, the Risatti CSF assay 
consistently resulted in the positive detection of BDV. 
Table 1. Development, optimization, and validation of a Classical swine fever virus real-time reverse transcription polymerase chain 
reaction assay: primer and probe sequences designed for the detection of viral RNA.*
Name Designation Tm Sequence Position
PIADC-F Forward 59 TGCCCAAGACACACCTTAACC 241–261
PIADC-R Reverse 58 GGCCTCTGCAGCGCCCTAT 314–332
PIADC-P Probe† 69 TGATGGGAGTACGACCTG 296–313
*PIADC = Plum Island Animal Disease Center; Tm = melting temperature of nucleotide sequence.
†Probes were labeled with 6-carboxyfluorescein (FAM) at the 5′ end and with minor groove-binding nonfluorescent quencher dye (MGBNFQ) at the 3′ end.
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Additional testing was conducted using a somewhat smaller 
representative panel of 21 CSFV, 6 BDV, and 5 BVDV iso-
lates, and pestivirus-negative samples resulted in similar 
sensitivities of 99% between the tests; however, the resulting 
specificities were 92% for the CSF PIADC assay and 68% 
for the Risatti CSF assay (Table 2). This indicates that the 
CSF PIADC assay is a more specific test and better suited as 
a surveillance tool because of the risks and consequences 
resulting from false-positive samples.
Sensitivities and LODs for the CSF PIADC and Risatti 
CSF assays were determined and compared using dilutions 
of RNA obtained from selected titered CSFV isolates. Only 
results from the final optimized assays comparing the CSF 
PIADC assay using ROX-supplemented Multiplex-NR 
chemistry on the ABI 7900HT and ABI 7500 platforms as 
compared to the Risatti CSF assay on the SmartCycler II 
platform are shown (Table 3).
Performance of the CSF PIADC assay during diagnostic 
sensitivity and specificity testing on nasal swab samples 
from the Dominican Republic resulted in 59 positive and 93 
negative reactions, while the Risatti CSF assay resulted in 
the detection of 54 positive and 98 negative reactions. This 
Table 2. Development, optimization, and validation of a Classical swine fever virus real-time reverse transcription polymerase chain 
reaction assay: comparison of threshold cycle values between assays and platforms used.*
Assay threshold cycle values
 PIADC CSF Risatti8 CSF
Pestivirus isolate Genotype Source ABI 7900HT SmartCycler II ABI 7900HT
CSFV  
 V.1081/94 10/12/01 PIADC 29.9 35.4 30.06
 Trem. Cong. 10/19/01 3.1 PIADC 21.84 25.96 22.89
 Visbek/Germany 1995 PIADC 22.89 42.95 33.99
 Parma 98 PIADC 27.57 25.81 21.8
 Vi 2837/38/Germany 99 PIADC 23.59 30.6 24.9
 CPA317-3 PIADC 21.29 26.92 23.06
 San Cristobal A tons PIADC 25.76 29.63 29.03
 Texen 8/98 Edo Mexico PIADC 33.44 NT 35.2
 Degen 7/98 Jalisco PIADC 28.86 42.81 30.36
 Texcoco 98 Mexico PIADC 30.44 38.3 31.8
 Percen 97 Mexico PIADC 24.02 29.54 25.32
 Ames Plaque PIADC 21.45 NT 22.51
 Guatamala 85053.02 PIADC 18.33 20.41 19.32
 Alfort: 10/19/01 PIADC 21.33 27.99 21.37
 VD Bergen: Aug 97 PIADC 23.63 25.81 23.14
 PAV 250 Vaccine 1.2 PIADC 33.51 UD 37.87
 Costa Rica PIADC 27.82 29.33 27.58
 Paderborn 2.1 PIADC 27.75 27.09 24.15
 DR Bavaro PIADC 33.75 39.47 32.47
 Brescia 1.2 PIADC 19.89 26.64 23.2
 Kanagawa 3.4 PIADC 32.22 25.8 24.05
BDV  
 Gifhorn CRL UD 29.27 28.61
 137/4 CRL UD 28.65 25.9
 Chemnitz CRL UD 28.27 24.56
 Moredun CRL UD 33.7 33.82
 Aveyron CRL UD 32.81 29.43
 Frijters CRL UD 31.22 29.58
BVDV  
 NADL 1 NADC UD UD UD
 Singer 1 PIADC UD UD UD
 HVT2 PIADC UD UD UD
 Costa Rica PIADC UD UD UD
 Rutten PIADC UD UD UD
*CSFV = Classical swine fever virus; BDV = Border disease virus; BVDV = Bovine viral diarrhea virus; PIADC = Plum Island Animal Disease Center; 
CRL = European Union Community Reference Laboratory; NADC = National Animal Disease Center; UD = undetected; NT = not tested.
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indicates a greater sensitivity (100%) for the CSF PIADC 
assay on diagnostic samples. The agreement in results com-
paring the CSF PIADC and Risatti CSF assays were evalu-
ated with Cohen kappa statistic and estimated at κ = 0.93 
(95% CI: 0.87, 0.99).
To further compare the CSF PIADC and Risatti CSF 
assays, a total of 22 pigs were experimentally infected intrana-
sally with 1 ml of CSFV Brescia (16 animals) or BDV (6 ani-
mals). Six uninfected pigs served as negative controls. 
Animals were evaluated daily for clinical signs. Following 
onset of clinical signs, animals were sampled by sterile nasal 
swabsm that were then placed into 1.5-ml sterile tubes contain-
ing 1 ml of Dulbecco minimal essential medium containing 
antibiotics and antimycotics.n Both assays detected CSFV 
equally from all 16 pigs experimentally infected with CSFV; 
however, the Risatti CSF assay also gave positive signals for 
animals experimentally infected with BDV revealing a lower 
specificity.
Overall, the CSF PIADC assay resulted in lower Ct values 
as compared to the Risatti CSF assay, regardless of amplifica-
tion platform. When comparing Ct values obtained for the 
CSF PIADC assay on the ABI 7900HT to the Risatti CSF 
assay on the SmartCycler II, there did not appear to be a 
strong linear relationship or strong linear agreement between 
the 2 platforms (Table 2). The 2 assays showed stronger lin-
ear relationship and linear agreement when both amplifica-
tions were conducted using the ABI 7900HT.
The estimated LODs ranged from <1 to 3.33 using the 
CSF PIADC assay and from <1 to 2.16 using the Risatti CSF 
assay (Table 3). Amplification efficiencies were 87% for the 
PIADC CSF assay on the ABI 7900HT and 63% and 86% for 
the Risatti CSF assay run on the SmartCycler II and ABI 
7900HT, respectively.
Intra-assay variability was evaluated for the CSF PIADC 
assay using the ABI 7900HT and the Risatti CSF assay using 
the SmartCycler II and ABI 7900HT. Estimated intra-assay 
variability for the PIADC CSF assay was 0.13 (95% CI: 0.10, 
0.16) as compared with 1.00 (95% CI: 0.81, 1.30) and 0.16 
(95% CI: 0.13, 0.21) for the Risatti CSF assay on the 
SmartCycler II and ABI 7900HT, respectively. Results sug-
gest similar well-to-well variability between the Risatti CSF 
and the PIADC CSF when amplified on the ABI 7900 HT, 
and also indicate greater tube-to-tube variation when the 
Risatti CSF assay is amplified using the SmartCycler II.
With all PIADC CSF assay testing of culture isolates and 
clinical material, the BDV, BVDV, and known negative sam-
ples resulted in negative reactions on both platforms and with 
all chemistries evaluated. In tests conducted with diagnostic 
samples using the ABI 7900HT, resulting Ct values were low-
est using the Multiplex-NR kit followed by the SuperScript III 
kit, and finally the Probe kit. In tests conducted with diagnos-
tic samples using the ABI 7500, Ct values were lowest using 
the SuperScript III as compared to the Multiplex-NR kit.
The cross-reactivity observed with the CSF Risatti assay 
and BDV RNA is likely due in part to the high level of 
sequence conservation shared among pestivirus 5′ untrans-
lated regions, making specific primer and probe designs chal-
lenging.1 Indeed, in the original development and optimization 
of the Risatti CSF assay,8 several BVDV (n = 6) and BDV 
(n = 3) isolates were tested. While no fluorogenic signal was 
detected using these near neighbor samples, no FAM thresh-
old levels were indicated. Furthermore, agarose gel electro-
phoresis revealed BVDV- and BDV-specific PCR amplicons 
of expected sizes indicating the potential for cross-reactive 
forward and reverse primers but a lack of probe affinity for 
BVDV and BDV in the Risatti CSF assay. In a follow-up 
diagnostic evaluation of the Risatti CSF assay,7 sensitivity 
and specificity were also evaluated. In this testing, sensitivity 
was reported as 100% while specificity was reported as 
89.9%. The specificity samples were negative nasal swabs 
Table 3. Development, optimization, and validation of a Classical swine fever virus (CSFV) real-time reverse transcription polymerase 
chain reaction assay: analytical sensitivity presented as the limit of detection for diverse CSFV isolates using various assays and 
platforms.*
Assay limit of detection
 PIADC CSF Risatti8 CSF
CSFV strain Titer ABI 7900HT† ABI 7500 Fast† SmartCycler II
Haiti 5 <1 ND <1
Brescia 6.05 <1 <1 <1
Paderborn 6.05 3.33 ND 2.11
Penjamo 6.55 1.55 ND 2.16
Kanagawa 3.3 1.65 ND <1
Guatemala 6.2 1.32 1.73 ND
Percen 5.8 1.99 <1 ND
VD Bergen 6.3 1.92 1.55 ND
Alfort 6.95 3.38 2.60 ND
*CSFV = Classical swine fever virus; PIADC = Plum Island Animal Disease Center; ND = not determined. Titer and LODs expressed as log
10
 TCID
50
/ml.
†Qiagen QuantiTect® Multiplex RT-PCR NoROX Kit supplemented with ROX.
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(n = 384) and did not include known pestivirus near neigh-
bors such as BVDV or BDV to challenge the assay.7
During a disease outbreak or in ongoing surveillance, 
high-throughput capabilities will be necessary to handle the 
high volumes of samples needing to be tested. The Risatti 
CSF assay was originally developed and validated only for 
single-tube extraction and amplification using a SmartCycler 
system.8 In contrast, the CSF PIADC assay described herein 
was developed to function on high-throughput 96-well plat-
forms including the ABI 7900HT and ABI 7500 systems. 
The greater specificity and versatility of the CSF PIADC 
assay, having equivalency on different chemistries and 
high-throughput 96-well diagnostic formats, will be a ben-
efit to meeting the needs of a national surveillance program 
or diagnostic surge in the event of a CSF outbreak.
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